Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0007 Transporter Info
Gene Name	SLC47A1
Transporter Name	Multidrug and toxin extrusion protein 1
Gene ID	55244
UniProt ID	Q96FL8

Post-Translational Modification of This DT
Overview of SLC47A1 Modification Sites with Functional and Structural Information
Sequence	M E A P E E P A P V R G G P E A T L E V R G S R C L R L S A F R E E L R A L L V L A G P A F L V Q L M V F L I S F I S S V F C G H L G K L E L D A V T L A I A V I N V T G V S V G F G L S S A C D T L I S Q T Y G S Q N L K H V G V I L Q R S A L V L L L C C F P C W A L F L N T Q H I L L L F R Q D P D V S R L T Q T Y V T I F I P A L P A T F L Y M L Q V K Y L L N Q G I V L P Q I V T G V A A N L V N A L A N Y L F L H Q L H L G V I G S A L A N L I S Q Y T L A L L L F L Y I L G K K L H Q A T W G G W S L E C L Q D W A S F L R L A I P S M L M L C M E W W A Y E V G S F L S G I L G M V E L G A Q S I V Y E L A I I V Y M V P A G F S V A A S V R V G N A L G A G D M E Q A R K S S T V S L L I T V L F A V A F S V L L L S C K D H V G Y I F T T D R D I I N L V A Q V V P I Y A V S H L F E A L A C T S G G V L R G S G N Q K V G A I V N T I G Y Y V V G L P I G I A L M F A T T L G V M G L W S G I I I C T V F Q A V C F L G F I I Q L N W K K A C Q Q A Q V H A N L K V N N V P R S G N S A L P Q D P L H P G C P E N L E G I L T N D V G K T G E P Q S D Q Q M R Q E E P L P E H P Q D G A K L S R K Q L V L R R G L L L L G V F L I L L V G I L V R F Y V R I Q
PTM type	X-Acetylation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Methionine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC47A1			[1]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	1
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC47A1 Methionine 1 has the potential to affect its expression or activity.
Phosphorylation
Serine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC47A1			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	23
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC47A1 Serine 23 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC47A1			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	29
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC47A1 Serine 29 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC47A1			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	258
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC47A1 Serine 258 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC47A1			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	17
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC47A1 Threonine 17 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Inhibiting the function of SLC47A1			[4]
Role of PTM	On/Off Switch
Affected Drug/Substrate	Cisplatin	Results for Drug	Decreasing uptake of cisplatin specificity
Modified Residue	Tyrosine
Modified State	Tyrosine kinase inhibitors (Pazopanib)
Experimental Material(s)	Human embryonic kidney (HEK) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at SLC47A1 Tyrosine (i.e. Tyrosine kinase inhibitors (Pazopanib)) have been reported to inhibit its transport function.
Ubiquitination
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC47A1			[5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	476
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC47A1 Lysine 476 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC47A1			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	536
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC47A1 Lysine 536 has the potential to affect its expression or activity.

References
1	N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54.
2	Mass spectrometric phosphoproteome analysis of small-sized samples of human neutrophils. Clin Chim Acta. 2015 Dec 7;451(Pt B):199-207.
3	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4	Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin. Pharmacol Res. 2016 Aug;110:89-95.
5	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
6	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021 Jun;594(7862):246-252.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence